Nebraska Methodist Hospital; Cancer Center — Omaha, Nebraska

Nebraska Methodist Hospital; Cancer Center is a clinical research site located in Omaha, Nebraska, United States 68114.

Crixeo Health Trust Score: 48/100 (POOR). This profile has not yet been claimed by the site owner.

Nebraska Methodist Hospital; Cancer Center has participated in 2 clinical trials.

Therapeutic areas: Urothelial Carcinoma, Colorectal Neoplasms.

Sponsors: Genentech, Inc., Hoffmann-La Roche.

Sponsor Feasibility Report

Trust Score: 48/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Nebraska Methodist Hospital; Cancer Center?

Nebraska Methodist Hospital; Cancer Center has a Crixeo Trust Score of 48/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Nebraska Methodist Hospital; Cancer Center conducted?

Nebraska Methodist Hospital; Cancer Center has 2 clinical trials on record. Their work covers Urothelial Carcinoma, Colorectal Neoplasms.

Is Nebraska Methodist Hospital; Cancer Center accredited by Crixeo Health?

Nebraska Methodist Hospital; Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Nebraska Methodist Hospital; Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.